Amarin Corporation PLC reports results for the quarter ended September 30 - Earnings Summary

• Amarin Corporation PLC reported quarterly adjusted earnings of 8 cents​​ per share for the quarter ended September 30, identical to the same quarter last year. The lone analyst forecast for the quarter was for a loss of 2 cents per share.

• Revenue fell 20.4% to $39.55 million from a year ago; analysts expected $43.71 million.

• Amarin Corporation PLC's reported EPS for the quarter was breakeven results​.

• The company reported quarterly net income of $245 thousand.

• Amarin Corporation PLC shares had fallen by 8.1% this quarter and lost 14.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "sell" and the breakdown of recommendations is no "strong buy" or "buy," no "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is "buy."

• Wall Street's median 12-month price target for Amarin Corporation PLC is $12.00, about 0.4% above its last closing price of $11.95

This summary was machine generated from LSEG data October 28 at 02:10 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)